Literature DB >> 23273607

Recent development of potent analogues of oxazolidinone antibacterial agents.

Katarzyna Michalska1, Izabela Karpiuk, Marek Król, Stefan Tyski.   

Abstract

The oxazolidinones are a new and potent class of antimicrobial agents with activity mainly against Gram-positive strains. The commercial success of linezolid, the only FDA-approved oxazolidinone, has prompted many pharmaceutical companies to devote resources to this area of investigation. Until now, four types of chemical modifications of linezolid and oxazolidinone-type antibacterial agents, including modification on each of the A-(oxazolidinone), B-(phenyl), and C-(morpholine) rings as well as the C-5 side chain of the A-ring substructure, have been described. Division into sections according to side chain modification or the type of ring will be used throughout this review, although the process of synthesis usually involves the simultaneous modification of several elements of the linezolid substructure; therefore, assignment into the appropriate section depends on the structure-activity relationships (SAR) studies. This review makes an attempt to summarise the work carried out in the period from 2006 until mid-2012.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23273607     DOI: 10.1016/j.bmc.2012.11.036

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  19 in total

1.  Potent oxazolidinone antibacterials with heteroaromatic C-ring substructure.

Authors:  Hideyuki Suzuki; Iwao Utsunomiya; Koichi Shudo; Takaji Fujimura; Masakatsu Tsuji; Issei Kato; Toshiaki Aoki; Akira Ino; Tsutomu Iwaki
Journal:  ACS Med Chem Lett       Date:  2013-09-22       Impact factor: 4.345

2.  Recent Advances in the Rational Design and Optimization of Antibacterial Agents.

Authors:  Jesse A Jones; Kristopher G Virga; Giuseppe Gumina; Kirk E Hevener
Journal:  Medchemcomm       Date:  2016-07-07       Impact factor: 3.597

Review 3.  Cadazolid: A new hope in the treatment of Clostridium difficile infection.

Authors:  Arunava Kali; Marie Victor Pravin Charles; Srirangaraj Srirangaraj
Journal:  Australas Med J       Date:  2015-08-31

Review 4.  Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.

Authors:  George G Zhanel; Riley Love; Heather Adam; Alyssa Golden; Sheryl Zelenitsky; Frank Schweizer; Bala Gorityala; Philippe R S Lagacé-Wiens; Ethan Rubinstein; Andrew Walkty; Alfred S Gin; Matthew Gilmour; Daryl J Hoban; Joseph P Lynch; James A Karlowsky
Journal:  Drugs       Date:  2015-02       Impact factor: 9.546

5.  Design, Synthesis, and Antibacterial Evaluation of Oxazolidinones with Fused Heterocyclic C-Ring Substructure.

Authors:  Mahesh S Deshmukh; Nidhi Jain
Journal:  ACS Med Chem Lett       Date:  2017-09-28       Impact factor: 4.345

6.  Synthesis and antifungal activity of novel oxazolidin-2-one-linked 1,2,3-triazole derivatives.

Authors:  Alejandra Ramírez-Villalva; Davir González-Calderón; Roxana I Rojas-García; Carlos González-Romero; Joaquín Tamaríz-Mascarúa; Macario Morales-Rodríguez; Nieves Zavala-Segovia; Aydeé Fuentes-Benítes
Journal:  Medchemcomm       Date:  2017-10-17       Impact factor: 3.597

7.  Cyto-genotoxicity Assessment of Potential Anti-tubercular Drug Candidate Molecule-trans-cyclohexane-1, 4-diamine Derivative-9u in Human Lung Epithelial Cells A549.

Authors:  Ekta Kapoor; Vinay Tripathi; Vivek Kumar; Vijay Juyal; Sunita Bhagat; Veerma Ram
Journal:  Toxicol Int       Date:  2014-01

Review 8.  Chemical Classes Presenting Novel Antituberculosis Agents Currently in Different Phases of Drug Development: A 2010-2020 Review.

Authors:  Klaudia T Angula; Lesetja J Legoabe; Richard M Beteck
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-13

9.  3-Aminooxetanes: versatile 1,3-amphoteric molecules for intermolecular annulation reactions.

Authors:  Zengwei Lai; Renwei Zhang; Qiang Feng; Jianwei Sun
Journal:  Chem Sci       Date:  2020-09-08       Impact factor: 9.825

10.  (4S)-4-[(R)-Chloro-(4-nitro-phen-yl)meth-yl]-1,3-oxazolidin-2-one.

Authors:  V Gaumet; C Denis; M Madesclaire; V P Zaitsev
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.